Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CB-11 by Cellebrain for Glioblastoma Multiforme (GBM): Likelihood of Approval
CB-11 is under clinical development by Cellebrain and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData, Phase...